Search

everythinglearnresearchcommunity

for

Search:↓

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

The document cannot be processed or understood.

New gene variants linked to a rare inherited hair loss disorder were found in three Chinese families.

The document's conclusion cannot be provided because the content is not available.

AMP-303 safely increases hair growth in men with hair loss.

A new diagnostic model can help better diagnose and understand Alopecia Areata.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

The study concluded that specific proteins are necessary to maintain the structure that holds epithelial cells tightly together.

Sorafenib can cause rare skin reactions, but treatment can continue with additional care.

The compounds tested could potentially treat hair loss and alopecia.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

The document contains an error.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

Different miRNAs in Rex rabbit skin affect cell processes and hair growth.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

In 2011, there were major scientific breakthroughs in cancer treatment, immunity, Parkinson's, virus simulation, schizophrenia, hair growth, lung cancer, and medical grafts.

The document's conclusion cannot be provided because the document cannot be parsed.

Two new mutations in the AR gene linked to severe androgen insensitivity were found.